Avila Raises First Round

Avila Therapeutics Inc., a Waltham, Mass.-based drug company focused on cancer and viral diseases, has raised an undisclosed amount of Series A funding, according to VentureWire. Abingworth Management led the deal, and was joined by Advent Venture Partners, Atlas Venture and Polaris Venture Partners.